EQL Pharma AB (publ) (STO: EQL)
Sweden
· Delayed Price · Currency is SEK
79.80
0.00 (0.00%)
At close: Dec 20, 2024
EQL Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | 31.18 | 22.71 | 30.92 | 31.55 | 10.37 | 2.71 | Upgrade
|
Depreciation & Amortization | 7.66 | 7.66 | 7.43 | 2.76 | - | 2.42 | Upgrade
|
Other Amortization | 0.62 | 0.62 | 1.14 | 0.78 | - | 0.34 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.47 | 0.47 | 7.84 | 6.73 | - | 1.38 | Upgrade
|
Other Operating Activities | 7.94 | 0.07 | 8.13 | 7.2 | 18.41 | - | Upgrade
|
Change in Accounts Receivable | -28.09 | -14.25 | -16.86 | -11.69 | -6.27 | -6.04 | Upgrade
|
Change in Inventory | -63.23 | -40.26 | -23.69 | 0.68 | -14 | -13.81 | Upgrade
|
Change in Other Net Operating Assets | 24.68 | 11.54 | 12.72 | 3.83 | 51.54 | 19.7 | Upgrade
|
Operating Cash Flow | -18.78 | -11.44 | 27.62 | 41.83 | 60.05 | 6.69 | Upgrade
|
Operating Cash Flow Growth | - | - | -33.98% | -30.34% | 797.97% | 12.98% | Upgrade
|
Capital Expenditures | -0.73 | -0.93 | -0.46 | -0.63 | -0.41 | -0.5 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.01 | Upgrade
|
Sale (Purchase) of Intangibles | -71.73 | -65.34 | -20.05 | -21.46 | -55.17 | -17.59 | Upgrade
|
Other Investing Activities | -0 | - | -0 | - | - | - | Upgrade
|
Investing Cash Flow | -72.46 | -66.26 | -20.51 | -22.09 | -55.58 | -18.08 | Upgrade
|
Long-Term Debt Issued | - | 53.97 | - | 0.6 | 12.88 | - | Upgrade
|
Long-Term Debt Repaid | - | -0.49 | -4.07 | -6.58 | -1.08 | - | Upgrade
|
Net Debt Issued (Repaid) | 82.03 | 53.48 | -4.07 | -5.98 | 11.8 | - | Upgrade
|
Issuance of Common Stock | 0.19 | 0.27 | 0.19 | 0.86 | - | - | Upgrade
|
Other Financing Activities | 0 | - | 0 | - | - | 0.01 | Upgrade
|
Financing Cash Flow | 82.23 | 53.74 | -3.88 | -5.12 | 11.8 | 0.01 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
Net Cash Flow | -9.02 | -23.96 | 3.23 | 14.62 | 16.27 | -11.38 | Upgrade
|
Free Cash Flow | -19.51 | -12.36 | 27.16 | 41.2 | 59.64 | 6.19 | Upgrade
|
Free Cash Flow Growth | - | - | -34.08% | -30.92% | 864.27% | 12.07% | Upgrade
|
Free Cash Flow Margin | -6.16% | -4.68% | 10.45% | 10.06% | 33.29% | 8.59% | Upgrade
|
Free Cash Flow Per Share | -0.67 | -0.43 | 0.92 | 1.42 | 2.05 | 0.21 | Upgrade
|
Cash Interest Paid | 8.38 | 4.01 | 2.29 | 2.78 | - | - | Upgrade
|
Cash Income Tax Paid | - | - | - | - | 0.06 | - | Upgrade
|
Levered Free Cash Flow | -105.78 | -89.53 | -9.9 | 1.84 | -60.68 | -28.91 | Upgrade
|
Unlevered Free Cash Flow | -100.57 | -85.95 | -8.42 | 3.64 | -59.99 | -28.64 | Upgrade
|
Change in Net Working Capital | 66.2 | 48.35 | 22.32 | 2.09 | 11.62 | 16.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.